Desmoglein‐2 expression is an independent predictor of poor prognosis patients with multiple myeloma

Multiple myeloma (MM) is the second most common haematological malignancy and is an incurable disease of neoplastic plasma cells (PC). Newly diagnosed MM patients currently undergo lengthy genetic testing to match chromosomal mutations with the most potent drug/s to decelerate disease progression. W...

Full description

Bibliographic Details

Published in:	Molecular Oncology
Main Authors:	Lisa M. Ebert, Kate Vandyke, M. Zahied Johan, Mark DeNichilo, Lih Y. Tan, Kay K. Myo Min, Benjamin M. Weimann, Brenton W. Ebert, Stuart M. Pitson, Andrew C. W. Zannettino, Craig T. Wallington‐Beddoe, Claudine S. Bonder
Format:	Article
Language:	English
Published:	Wiley 2022-03-01
Subjects:	adhesion bone marrow desmoglein‐2 multiple myeloma plasma cells prognostic
Online Access:	https://doi.org/10.1002/1878-0261.13055